Axcelis Tech Ord Stock Price, News & Analysis

Axcelis Technologies (ACLS) reported robust financial results for Q2 2022, achieving $221.2 million in revenue, a rise from $203.6 million in Q1. The operating profit increased to $54.1 million, with net income at $44.2 million or $1.32 per diluted share. Gross margin improved to 44.8%. The company experienced record system bookings of $432.8 million and backlog reaching $869.5 million. For FY 2022, revenue is projected to exceed $875 million, with a gross margin of approximately 42.5%.

Axcelis Technologies (Nasdaq: ACLS) has officially opened its new Axcelis Asia Operations Center in Pyeongtaek-Si, Korea, significantly increasing its manufacturing capacity. The state-of-the-art facility spans over 44,000 square feet and is certified by ISO 45001 for occupational health and safety. Initial shipments commenced in Q1, and the center aims to enhance customer relationships and streamline operations across Asia. This investment is expected to create numerous local jobs in various functions.

Axcelis Technologies (Nasdaq: ACLS) announced robust financial expectations for Q2 2022, projecting revenues exceeding $215 million, a gross margin of approximately 41%, operating profit around $41 million, and earnings per diluted share of about $1.00. The company cites strong demand for ion implantation solutions within the semiconductor sector, with booking levels supporting over $850 million in total revenue for the year. A conference call is scheduled for August 4, 2022, to discuss these results in further detail.

Axcelis Technologies (Nasdaq: ACLS) has announced significant progress in the power device segment with multiple shipments of its Purion H200 Si 200mm and SiC Power Series™ 150mm high current implanters to major power device chipmakers in Asia. These systems are intended for high-volume production in the automotive sector, which is experiencing rapid growth.

Executive Vice President Bill Bintz stated that the power device segment is projected to comprise 30% to 40% of their system sales in 2022, highlighting the company's commitment to support electric vehicle technology through advanced manufacturing solutions.

Axcelis Technologies (NASDAQ: ACLS) is set to participate in the 14th Annual CEO Summit on July 13, 2022, taking place at the St. Regis Hotel in San Francisco, CA. This event allows accredited investors and research analysts to engage with the management teams of various participating companies. Axcelis, a leader in ion implantation solutions for the semiconductor industry, will make presentation materials available on its investor page. Early RSVP is advised as space is limited, with the registration deadline on July 1, 2022.

Axcelis Technologies (Nasdaq: ACLS) reported multiple shipments of Purion M™ medium current implanters, enhancing its presence in the semiconductor industry. These include follow-on orders and three new placements across the US, Europe, and Asia, shipped in Q2 2022. Executive VP Bill Bintz noted that the mature process technology market continues to be robust, indicating potential revenue growth from these new tool placements. This strategic move aims to expand the company's customer base and revenues in a vital segment of the industry.

Axcelis Technologies (NASDAQ: ACLS) has announced its participation in several upcoming investor conferences. Key events include the 22nd Annual B. Riley Institutional Investor Conference on May 25 in Beverly Hills, CA, featuring a fireside chat by management. Other conferences include the Craig-Hallum Institutional Investor Conference on June 1, the Cowen Technology, Media & Telecom Conference on June 2, and the Stifel 2022 Cross Sector Insight Conference on June 8, where management will also present and conduct meetings. A live webcast will be available for the Stifel event.

Axcelis Technologies reported strong first-quarter results for 2022, with revenue of $203.6 million, slightly down from Q4 2021. The company achieved an operating profit of $48.9 million and net income of $41.6 million, or $1.22 per diluted share. A record backlog of $625.1 million and bookings of $315.5 million were reported, alongside cash of $297.9 million. The company anticipates exceeding $850 million in revenue for 2022. Despite supply chain challenges affecting margins, an optimistic outlook for the second quarter predicts revenues between $205-215 million.

Axcelis Technologies (Nasdaq: ACLS) announced the shipment of two Purion H™ high current implanter evaluation systems in Q2 2022 to major chipmakers in Asia. These systems will assist in the production of DRAM memory and mature process technology devices. President and CEO Mary Puma highlighted the growth opportunities presented by these installations, emphasizing the superior process control and productivity offered by the Purion H technology.